Kazia Therapeutics price target maintained at $40 by BTIG
BTIG maintained a $40.00 per share price target on Kazia Therapeutics, according to Benzinga/TradingView News ratings actions.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Kazia Therapeutics maintained at Buy as BTIG raises target
BTIG maintained Kazia Therapeutics at Buy and raised its price target to $40.00 per share from $34.00, according to Benzinga via TradingView News.